Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8682 |
Vazegepant hydrochloride
Vazegepant HCl |
CGRP Receptor | GPCR/G Protein; Neuroscience |
Vazegepant hydrochloride (Vazegepant HCl) 是一种用于偏头痛的鼻用 gepant,是一种高度亲和性CGRP 受体拮抗剂 (hCGRPKi=0.023 nM)。它可能有助于有效管理 COVID-19 相关肺部炎症。 | |||
T12293L |
Olcegepant
BIBN-4096,BIBN 4096BS |
CGRP Receptor | GPCR/G Protein; Neuroscience |
Olcegepant (BIBN-4096) 是一种选择性的降钙素基因相关肽1 (CGRP1) 受体拮抗剂,IC50=0.03 nM,Ki=14.4 pM。 | |||
T17194 |
Ubrogepant
MK-1602 |
CGRP Receptor | GPCR/G Protein; Neuroscience |
Ubrogepant (MK-1602) 是新型的、口服有效的降钙素基因相关肽受体拮抗剂。Ubrogepant 有潜力用于急性偏头痛的相关研究。 | |||
T4610 |
Rimegepant
BMS 927711,BMS-927711,BMS927711,BHV-3000 |
CGRP Receptor | GPCR/G Protein; Neuroscience |
Rimegepant (BMS 927711) 是一种有效的降钙素基因相关肽 (CGRP) 受体拮抗剂,其 Ki=0.027 nM,IC50=0.14 nM。 | |||
T12293 |
Olcegepant hydrochloride
BIBN-4096 hydrochloride,BIBN4096BS hydrochloride |
Others | Others |
Olcegepant hydrochloride is a potent and selective non-peptidethe calcitonin gene-related peptide 1 (CGRP1) receptor antagonist (with IC50 of 0.03 nM for human CGRP). | |||
T73703 | (3R,5R,6S)-Atogepant | ||
(3R,5R,6S)-Atogepant ((3R,5R,6S)-MK-8031) 是Atogepant 的异构体.Atogepant 是降钙素基因相关肽受体 (CGRP) 拮抗剂。Atogepant 可用于研究偏头痛。 | |||
T26682 |
Atogepant
MK 8031,MK8031. Atogepant,MK-8031 |
||
Atogepant is an antagonist of calcitonin gene-related peptide receptor. | |||
T70837 | Rimegepant sulfate hydrate | ||
Rimegepant, also known as BMS-927711 and BHV-3000, is a potent, selective, competitive, and orally active calcitonin gene-related peptide (CGRP) antagonist in clinical trials for treating migraines. Rimegepant has shown in vivo efficacy without vasoconstriction effect. BMS-927711 is superior to placebo at several different doses (75 mg, 150 mg, and 300 mg) and has an excellent tolerability profile. | |||
T16093 |
Telcagepant
MK-0974 |
Others | Others |
Telcagepant is an orally active antagonist of calcitonin gene-related peptide (CGRP) receptor (Kis: 0.77 nM and 1.2 nM for human and rhesus CGRP receptors, respectively). | |||
T38734 |
Vazegepant
Zavegepant,BHV-3500 |
||
Vazegepant is an intranasal CGRP receptor antagonist utilized for conducting acute migraine research. |